Multiple pathways in prevention of immune-mediated brain disorders: Implications for the prevention of autism

Journal of Neuroimmunology

Volumn 217, Issue 1-2, 2009, Pages 8-9

  Fatemi, S Hossein ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; AMYLOID BETA PROTEIN; ANTIVIRUS AGENT; DIOSMIN; FLAVONOID; GLITAZONE DERIVATIVE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 21; INTERLEUKIN 27; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; JANUS KINASE 2; LEPTIN; LUTEOLIN; MACROLIDE; OSELTAMIVIR; PENTOXIFYLLINE; PROTEIN BCL 2; PROTEIN P53; REELIN; STAT3 PROTEIN; VACCINE;

ALZHEIMER DISEASE; AUTISM; BACTERIAL IMMUNITY; BEHAVIOR DISORDER; DRUG MECHANISM; EDITORIAL; GABAERGIC SYSTEM; HUMAN; INFLUENZA VIRUS A H1N1; NEUROIMMUNOLOGY; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; VIRUS IMMUNITY;

ANIMALS; BRAIN DISEASES; MICE; SIGNAL TRANSDUCTION;

EID: 70449631011     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.09.011     Document Type: Editorial

References (42)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed (1994), APA Press, Washington, DC
2. Bailey A., Le Couteur A., Gottesman I., Bolton P., Simonoff E., Yuzda E., and Rutter M. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25 (1995) 63-77
3. Blatt G.J. GABAergic cerebellar system in autism: a neuropathological and developmental perspective. Int. Rev. Neurobiol. 71 (2005) 167-178
4. Boris M., Kaiser C.C., Goldblatt A., Elice M.W., Edelson S.M., Adams J.B., and Feinstein D.L. Effect of pioglitazone treatment on behavioral symptoms in autistic children. J. Neuroinflammation 4 (2007) 3
5. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr. Bull. 32 (2006) 200-202
6. Casanova M.F., Buxhoeveden D.P., Switala A.E., and Roy E. Minicolumnar pathology in autism. Neurology 58 (2002) 428-432
7. Cattaneo E., Conti L., and De-Fraja C. Signalling through the JAK-STAT pathway in the developing brain. Trends Neurosci. 22 8 (1999) 365-369
8. Chiba T., Yamada M., Sasabe J., Terashita K., Shimoda M., Matsuoka M., and Aiso S. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol. Psychiatry 14 (2009) 206-222
9. Courchesne E., Carper R., and Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 290 (2003) 337-344
10. Fatemi S.H., and Halt A.R. Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism. Synapse 42 (2001) 281-284
11. Fatemi S.H., Emamian E.S., Kist D., Sidwell R.W., Nakajima K., Akhter P., Shier A., Sheikh S., and Bailey K. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol. Psychiatry 4 (1999) 145-154
12. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schulz S.C., and Realmuto G.R. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52 (2002) 805-810
13. Fatemi S.H., Pearce D.A., Brooks A.I., and Sidwell R.W. Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse 57 (2005) 91-99
14. Fatemi S.H., Snow A.V., Stary J.M., Araghi-Niknam M., Reutiman T.J., Lee S., Brooks A.I., and Pearce D.A. Reelin signaling is impaired in autism. Biol. Psychiatry 57 (2005) 777-787
15. Fatemi S.H., Reutiman T.J., Folsom T.D., Huang H., Oishi K., Mori S., Smee D.F., Pearce D.A., Winter C., Sohr R., and Juckel G. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr. Res. 99 (2008) 56-70
16. Fatemi S.H., Folsom T.D., Reutiman T.J., and Thuras P.D. Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum 8 (2009) 64-69
17. Fatemi S.H., Reutiman T.J., Folsom T.D., and Thuras P.D. GABA(A) receptor downregulation in brains of subjects with autism. J. Autism Dev. Disord. 39 (2009) 223-230
18. Kaplan J.M., Herzyk D.J., Ruggieri E.V., Bartus J.O., Esser K.M., and Bugelski P.J. Effect of TNF alpha production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:C. Toxicology 95 (1995) 187-196
19. Kido H., Okumura Y., Yamada H., Le T.Q., and Yano M. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. Curr. Pharm. Des. 13 (2007) 405-414
20. Laurence J.A., and Fatemi S.H. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 4 (2005) 206-210
21. Liu A.L., Liu B., Qin H.L., Lee S.M., Wang Y.T., and Du G.H. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med. 74 (2008) 847-851
22. Meyer U., Feldon J., and Fatemi S.H. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci. Biobehav. Rev. 33 (2009) 1061-1079
23. Miyamoto D., Hasegawa S., Sriwilaijaroen N., Yingsakmongkon S., Hiramatsu H., Takahashi T., Hidari K., Guo C.T., Sakano Y., Suzuki T., and Suzuki Y. Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells. Biol. Pharm. Bull. 31 (2008) 217-222
24. Nagai T., Moriguchi R., Suzuki Y., Tomimori T., and Yamada H. Mode of action of the anti-influenza virus activity of plant flavonoid, 5, 7, 4'-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis. Antivir. Res. 26 (1995) 11-25
25. Oblak A., Gibbs T.T., and Blatt G.J. Decreased GABA(A) receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism. Autism Res. 2 (2009) 205-219
26. Palmen S.J., van Engeland H., Hof P.R., and Schmitz C. Neuropathological findings autism. Brain 127 (2004) 2572-2583
27. Pang Y., Fan L.W., Zheng B., Cai Z., and Rhodes P.G. Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats. Neuroscience 141 (2006) 745-755
28. Parker-Athill E., Lou D., Bailey A., Giunta B., Tian J., Shytle D., Murphy T., and Legradi G. Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism. J. Neuroimmunol. 217 (2009) 20-27
29. Patterson P.H. Maternal effects on schizophrenia risk. Science 318 (2007) 576-577
30. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology, and animal models. Behav. Brain Res. 204 (2009) 313-321
31. Penner J.D., and Brown A.S. Prenatal infectious and nutritional factors and risk of adult schizophrenia. Expert Rev. Neurother. 7 (2007) 797-805
32. Perry E.K., Lee M.L., Martin-Ruiz C.M., Court J.A., Volsen S.G., Merrit J., Folly E., Iversen P.E., Bauman M.L., Perry R.H., and Wenk G.L. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry 158 (2001) 1058-1066
33. Realmuto G.M., and Azeem M.W. Autistic disorder. In: Fatemi S.H., and Clayton P. (Eds). The Medical Basis of Psychiatry (2008), Humana Press, New York 355-374
34. Saltzman A., Stone M., Franks C., Searfoss G., Munro R., Jaye M., and Ivashchenko Y. Cloning and characterization of human Jak-2 kinase: high mRNA expression in immune cells and muscle tissue. Biochem. Biophys. Res. Commun. 246 (1998) 627-633
35. Schindler C., Levy D.E., and Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282 (2007) 20059-20063
36. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. A mouse model of mental illness: maternal influenza infection causes behavioral and pharmacological abnormalities in the offspring. J. Neurosci. 23 (2003) 297-302
37. Smith S.E., Li J., Garbett K., Mirnics K., and Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 27 (2007) 10695-10702
38. Sriram K., Benkovic S.A., Hebert M.A., Miller D.B., and O'Callaghan J.P. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?. J. Biol. Chem. 279 (2004) 19936-19947
39. Stephanou A., and Latchman D.S. Opposing actions of STAT-1 and STAT-3. Growth Factors 23 (2005) 177-182
40. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57 (2005) 67-81
41. Wang X., Jia W., Zhao A., and Wang X. Anti-influenza agents from plants and traditional Chinese medicine. Phytother. Res. 20 (2006) 335-341
42. Zhang H., Su Y.A., Hu P., Yang J., Zheng B., Wu P., Peng J., Tang Y., and Zhang L. Signature patterns revealed by microarray analyses of mice infected with influenza virus A and Streptococcus pneumoniae. Microbes Infect. 8 (2006) 2172-2185